Susquehanna International Group’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Hold
0
6768
2024
Q2
Sell
-950,839
Closed -$4.11M 6787
2024
Q1
$4.11M Sell
950,839
-627,762
-40% -$2.71M ﹤0.01% 1165
2023
Q4
$4.81M Buy
+1,578,601
New +$4.81M ﹤0.01% 1174
2023
Q3
Sell
-12,471
Closed -$31.1K 6565
2023
Q2
$31.1K Sell
12,471
-308,802
-96% -$769K ﹤0.01% 5294
2023
Q1
$861K Sell
321,273
-56,519
-15% -$151K ﹤0.01% 3107
2022
Q4
$2.05M Buy
377,792
+203,830
+117% +$1.11M ﹤0.01% 1573
2022
Q3
$2.17M Buy
173,962
+109,034
+168% +$1.36M ﹤0.01% 1585
2022
Q2
$321K Sell
64,928
-34,467
-35% -$170K ﹤0.01% 3919
2022
Q1
$755K Sell
99,395
-99,341
-50% -$755K ﹤0.01% 3166
2021
Q4
$2.03M Buy
198,736
+34,290
+21% +$350K ﹤0.01% 1960
2021
Q3
$2.21M Buy
164,446
+83,653
+104% +$1.12M ﹤0.01% 1860
2021
Q2
$1.77M Sell
80,793
-52,651
-39% -$1.16M ﹤0.01% 2203
2021
Q1
$3.21M Sell
133,444
-79,470
-37% -$1.91M ﹤0.01% 1615
2020
Q4
$3.83M Buy
212,914
+157,546
+285% +$2.83M ﹤0.01% 1204
2020
Q3
$640K Buy
55,368
+38,358
+226% +$443K ﹤0.01% 2758
2020
Q2
$413K Sell
17,010
-9,110
-35% -$221K ﹤0.01% 3131
2020
Q1
$288K Buy
26,120
+16,583
+174% +$183K ﹤0.01% 3468
2019
Q4
$252K Sell
9,537
-14,561
-60% -$385K ﹤0.01% 3299
2019
Q3
$549K Sell
24,098
-10,939
-31% -$249K ﹤0.01% 2792
2019
Q2
$1.07M Buy
+35,037
New +$1.07M ﹤0.01% 1956
2019
Q1
Hold
0
4771
2018
Q4
Hold
0
5079
2018
Q3
Hold
0
4915